title: [Evaluation on HIV antibody testing strategy currently used in China].
abstract: OBJECTIVE
  To evaluate the yield of HIV antibody testing strategy currently used on different populations, in China.
  
  
  METHODS
  (1) The following samples were collected and tested according to the currently used HIV antibody testing strategy in China. 103 133 samples from the general populations (outpatients, new recruits and blood donors), 1276 people under high risk (spouses of the HIV infected individuals, intravenous drug users) and 2323 biochemical or immunological abnormal samples. (2) Retrospective analysis was done on data from the HIV testing among outpatients in General Hospital of People's Armed Police Forces, from Jan., 2002 to Dec., 2008 and in three provincial central HIV test and confirmatory laboratories.
  
  
  RESULTS
  (1) The yields of HIV antibody screening were significantly different in different populations. The probability of screening reactive to be true positive was 50% in high risk population, significantly higher than in the general population. The probability of screening reactive to be true positive was 19.58% in the confirmatory laboratory mainly towards the general population, but significantly lower than results from the confirmatory laboratories done on the high risk population. (2) From 2002 to 2008, in the General Hospital of People's Armed Police Forces, the probability of screening reactive to be true positive in the clinical HIV test was increasing from 3.7% to 16.0%, where as the efficiency of the repeat screening testing decreased from 92.6% to 61.5%.
  
  
  CONCLUSIONS
  The predictive value of HIV antibody screening reactive was significantly greater in high risk population than in general population. The precision of HIV antibody initial screening was substantially increased with the improvement of HIV antibody test kits and of quality control in the HIV test laboratories in recent years. It is suggested that different HIV test strategies to be implemented in different populations.
authors.affiliation: Institute of Microbiology & Epidemiology, Academy of Military Medical Science, State Key Laboratory of Pathogen and Biosecurity, PLA HIV Test Center, Beijing 100071, China.
authors.forename: Xiao-li
authors.initials: XL
authors.lastname: Yang
authors.forename: Zuo-yi
authors.initials: ZY
authors.lastname: Bao
authors.forename: Yong-jian
authors.initials: YJ
authors.lastname: Liu
authors.forename: Hai-shan
authors.initials: HS
authors.lastname: Geng
authors.forename: Qin-fang
authors.initials: QF
authors.lastname: Hao
authors.forename: Li
authors.initials: L
authors.lastname: Wang
authors.forename: Ai-qin
authors.initials: AQ
authors.lastname: Ling
authors.forename: Hai-yan
authors.initials: HY
authors.lastname: Wang
authors.forename: Jing-yun
authors.initials: JY
authors.lastname: Li
mesh_terms: D002681:China; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000097:blood / Q000175:diagnosis*; D006679:HIV Seropositivity; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D011237:Predictive Value of Tests; D012189:Retrospective Studies
chemical_list: D015483:HIV Antibodies